^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

20D9-ADC

i
Other names: 20D9-ADC
News
Trials
Company:
Tubulis
Drug class:
FLT3-targeted antibody-drug conjugate
Related drugs:
News
Trials